Collins Helen Louise 4
4 · Kura Oncology, Inc. · Filed Jun 6, 2025
Insider Transaction Report
Form 4
Collins Helen Louise
Director
Transactions
- Award
Option to purchase common stock
2025-06-05+28,500→ 28,500 totalExercise: $6.57Exp: 2035-06-04→ Common Stock (28,500 underlying)
Footnotes (1)
- [F1]This option vests in full on the one year anniversary of the date of grant.